MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0959
-0.0003 (-0.31%)
As of 2:33PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.0962
Open0.0955
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0900 - 0.1010
52 Week Range0.0600 - 0.1900
Volume4,539,098
Avg. Volume7,459,834
Market Cap313.656M
Beta-0.48
PE Ratio (TTM)N/A
EPS (TTM)-0.0450
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire6 hours ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Hosts Exclusive Premium Humulus Oil Training Webinar on July 17

    SAN DIEGO, July 16, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway® will host an exclusive premium humulus training webinar to answer questions about its new Premium Humulus Oil product on July 17, 2018. The primary ingredient in Premium Humulus Oil is ImmunAg™, a Kriya brand Humulus extract and the first cannabidiol (CBD) oil supplement not derived from the cannabis plant. Dr. Stuart Titus, CEO of Medical Marijuana, Inc., ImmunAg™ creator and partner Dr. Bomi Joseph, and Blake Schroeder, CEO of Kannaway® will answer viewer questions and discuss the history of the product.

  • PR Newswire4 days ago

    Six-Time Gold Medalist Amy Van Dyken Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

    SAN DIEGO, July 12, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that six-time Olympic gold medalist Amy Van Dyken has become a spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of cannabidiol (CBD) for athletes, former athletes and those who are just looking to lead a healthy, active lifestyle. "We're thrilled to work with Mrs. Van Dyken and to continue the conversation about the benefits that former athletes like her are experiencing from using CBD," said Kannaway® CEO Blake Schroeder. Kannaway® is the first hemp lifestyle network to legally offer hemp-based botanical CBD wellness products.

  • Medical Marijuana, Inc. Subsidiary Kannaway® Announces New THC-Free CBD Hemp Oil for Pets
    PR Newswire5 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces New THC-Free CBD Hemp Oil for Pets

    SAN DIEGO, July 11, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® has released a Tetrahydrocannabinol (THC)-free cannabidiol (CBD) hemp oil for pets called Dante's Pure Hemp Oil. Dante's Pure Hemp Oil is a THC-free CBD hemp oil that contains 1000 mg of CBD combined with MCT oil. "We are excited to announce this new product at a time where there is an increase in studies being conducted on the therapeutic benefits of CBD for a variety of animals," said Kannaway® CEO Blake Schroeder.

  • PR Newswire6 days ago

    Forbes Covers Medical Marijuana, Inc. Subsidiary HempMeds® Mexico's Recent International Expansion, Interviews HempMeds® Latin America President

    SAN DIEGO, July 10, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® has garnered international news coverage on leading business news website Forbes. A July 9, 2018, article on the Forbes website entitled "Mexico Could Make History By Treating CBD Like A Supplement, As It Should Be" talks about the many potential health and wellness benefits of cannabidiol (CBD) and quotes Raul Elizalde, President of HempMeds® Latin America, explaining how CBD should be sold in Mexico and what an impact legalizing recreational cannabis could have on the country's decades-long, cross-border drug war.

  • PR Newswire11 days ago

    Medical Marijuana, Inc. and Subsidiaries Announce June 2018 as the Largest Sales Month in Company History

    SAN DIEGO , July 5, 2018 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that both the Company and its subsidiaries  ...

  • Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Release of Its First CBD Vape Cartridge
    PR Newswire13 days ago

    Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Release of Its First CBD Vape Cartridge

    SAN DIEGO , July 3, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , announced today that its subsidiary Dixie Botanicals ® has ...

  • PR Newswire17 days ago

    Medical Marijuana, Inc. Applauds Oklahoma Voters for Legalizing Medical Marijuana

    SAN DIEGO , June 29, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today that the company applauds Oklahoma ...

  • PR Newswire18 days ago

    Medical Marijuana, Inc. Appoints New Director of Canadian Operations

    SAN DIEGO, June 28, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Kenneth Smith has been hired as the company's Director of Canadian Operations. Last week, Medical Marijuana, Inc. announced its partnership with Canadian cannabis company Salvation Botanicals and Smith will now serve as the liaison for this partnership.

  • PR Newswire20 days ago

    Medical Marijuana, Inc. Announces Partnership with Peak Health to Sell First-Ever and Only Hops-Derived Cannabidiol (CBD) Product, ImmunAG™

    SAN DIEGO, June 26, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it has partnered with Peak Health to distribute the first-ever, and only, hops (Kriya brand Humulus)-derived cannabidiol (CBD) product, ImmunAg™. Medical Marijuana, Inc. is the exclusive distributor of ImmunAG™ and the product will be sold as Real Scientific Humulus Oil (RSHO-K) by Medical Marijuana, Inc.'s distribution subsidiary, HempMeds®. Unlike CBD products derived from cannabis, which may contain trace amounts of Tetrahydrocannabinol (THC), ImmunAG™ contains no THC.

  • PR Newswire20 days ago

    Peak Health and ImmunAG™ Announce Partnership with Medical Marijuana, Inc. To Sell First-Ever And Only Hops-Derived Cannabidiol (CBD) Product, ImmunAG™

    LOS GATOS, Calif., June 26, 2018 /PRNewswire/ --  Peak Health and ImmnuAG™ announce today that they have partnered with Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, to distribute the first-ever, and only, hops (Kriya brand Humulus)-derived cannabidiol (CBD) product, ImmunAg™. The product will be sold as Real Scientific Humulus Oil (RSHO-K) by Medical Marijuana, Inc.'s distribution subsidiary, HempMeds®. Unlike CBD products derived from cannabis, which may contain trace amounts of Tetrahydrocannabinol (THC), ImmunAG™ contains no THC.

  • PR Newswire25 days ago

    Medical Marijuana, Inc. Announces Letter of Intent with Salvation Botanicals to Bring Its Products to the Burgeoning Canadian Cannabis Market

    SAN DIEGO, June 21, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it has signed a non-binding Letter of Intent (LOI) with Salvation Botanicals, Ltd., ("Salvation") to bring its internationally recognized cannabis products to the quickly growing Canadian cannabis market. According to Deloitte, the legal cannabis industry in Canada has the potential to generate over $4 billion in recreational sales within its first year. Medical Marijuana, Inc. produces industry-leading cannabidiol (CBD) brands including Real Scientific Hemp Oil™ (RSHO™), Dixie Botanicals® and Cannabis Beauty Defined® in the United States for distribution internationally.

  • PR Newswire26 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Norberto Fischer as New Company Spokesperson

    SAN DIEGO, June 20, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that Norberto Fischer has joined as spokesperson for the company. "We're very excited to have Norberto, a very close friend of the company, join us as a spokesperson and help share his story about how CBD helps improve the quality of life for his daughter, Anny," said HempMeds® Brasil Vice President Caroline Heinz.

  • PR Newswire27 days ago

    The History Channel's Award-Winning Television Series "Innovations with Ed Begley Jr." Features Medical Marijuana, Inc.

    SAN DIEGO , June 19, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it has garnered national news coverage ...

  • InvestorPlace28 days ago

    GW Pharmaceuticals’ New Drug Is a Step Toward Marijuana Legalization

    The news that GW Pharmaceuticals PLC (ADR) (NASDAQ:GWPH) will soon see Epidiolex, the company’s experimental drug that treats epilepsy, is fantastic in and of itself. Here’s why Epidiolex’s approval should matter to everyone participating in the burgeoning cannabis industry and not just GWPH shareholders. The biggest problem facing the cannabis industry at the moment as it pertains to Cannabidiol (CBD), the main ingredient of Epidiolex, is that hemp-derived CBD is technically considered legal throughout the U.S. as a result of the Agricultural Act of 2014 and exempted from Drug Enforcement Administration (DEA) regulation under a 2006 law, while marijuana-derived CBD is only legal in 30 states and Washington, D.C.

  • PR Newswirelast month

    Medical Marijuana, Inc. Applauds DEA's Recent Clarification on CBD; Company's Products Federally Legal

    SAN DIEGO, June 14, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, announced today that the company applauds the Drug Enforcement Administration (DEA) for its recent statement on the legality of cannabidiol (CBD) -- which further clarifies that some CBD products, such as hemp-derived CBD products sold by Medical Marijuana, Inc., are legal to distribute freely throughout the United States and do not fall under the regulations of the Controlled Substances Act (CSA). "Products and materials that are made from the cannabis plant and which fall outside the CSA definition of marijuana (such as sterilized seeds, oil or cake made from the seeds, and mature stalks) are not controlled under the CSA.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary HempMeds® Announces Import Permits for First-Ever THC-Free CBD Product in Argentina

    SAN DIEGO, June 13, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® today announced the historic authorization of its Real Scientific Hemp Oil-X™ (RSHO-X™) cannabidiol (CBD) hemp oil product for import into Argentina. Argentina's National Administration of Medicines, Food and Medical Technology (ANMAT) has approved the product for import. "As a company of firsts, we're proud to offer the first THC-free CBD product in Argentina," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

  • Phyto Animal Health, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Professional Rodeo Rider Jennifer Arnold and Husband Brad Arnold of 3 Doors Down
    PR Newswirelast month

    Phyto Animal Health, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Professional Rodeo Rider Jennifer Arnold and Husband Brad Arnold of 3 Doors Down

    SAN DIEGO, June 12, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Phyto Animal Health has announced a partnership with Professional Rodeo Star Jennifer Arnold and her husband Brad Arnold, lead singer of Grammy Award-nominated multi-platinum Mississippi rock band 3 Doors Down. Phyto Animal Health offers a line of cannabidiol (CBD) hemp oil supplements and hemp products targeted to cats, dogs and horses. CBD hemp oil has been researched by top veterinarians for cardiovascular, orthopedic and mental animal health.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces May 2018 as the Largest Revenue Sales Month in Company History

    SAN DIEGO , June 7, 2018 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that its subsidiary  Kannaway® booked ...

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary HempMeds® President, Latin America Speaks at International Cannabis Summit in Guanajuato, Mexico

    SAN DIEGO, June 6, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® President, Latin America Raul Elizalde spoke at the international cannabis seminar CannaMexico World Summit on May 30-31 at the San Cristobal Center in León Guanajuato, Mexico. There, Elizalde presented on the therapeutic benefits of cannabinoids and the work that HempMeds® Mexico has been doing to increase access to cannabidiol (CBD) in Mexico. Grace was diagnosed with a rare and severe form of childhood epilepsy called Lennox-Gastaut Syndrome (LGS) which triggers up to 400 seizures a day. Grace was the first patient to be granted special permission in 2015 to legally import CBD into Mexico.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds HempBone Bacon Apple Donuts to CBD Pet Product Line

    SAN DIEGO , June 5, 2018 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , subsidiary Phyto Animal Health today announced its ...

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Applauds New Market Opportunities for CBD, United Nations World Health Organization Hosts 40th Expert Committee on Drug Dependence Meeting

    SAN DIEGO , May 30, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today that the company applauds the United ...

  • PR Newswire2 months ago

    Medical Marijuana, Inc. CEO to Speak on Medical Cannabis Research at 5th Annual Cannabis World Congress and Business Expo in New York

    SAN DIEGO, May 29, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that at the 5th Annual Cannabis World Congress and Business Expo (CWCBE), taking place in New York City from May 31-June 2, the company's Chief Executive Officer Dr. Stuart Titus will speak on medical cannabis and cannabidiol (CBD) research on May 31. Medical Marijuana, Inc. subsidiary HempMeds® will also be showing retail-ready cannabis products and exhibiting its line of CBD hemp oil products at the Expo in booth #100.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Announces Q1 2018 as the Largest Sales Revenue Quarter in Company History: Shows Gross Revenue Increase Exceeding 190%

    SAN DIEGO , May 23, 2018 /PRNewswire/ -- Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the company and its subsidiaries ...

  • PR Newswire2 months ago

    Dateline NBC Segment Features Medical Marijuana, Inc. Portfolio Company Kannalife Sciences

    SAN DIEGO, May 22, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) announced today that portfolio company Kannalife Sciences, Inc. ("Kannalife"), a bio-pharmaceutical and phyto-medical company, was featured in a Dateline NBC segment discussing how their research on cannabidiol (CBD)-like molecules could potentially change the landscape for various ailments including chronic traumatic encephalopathy (CTE) and the opioid epidemic. The May 20, 2018, segment entitled "Growing Promise" took an in-depth look into Kannalife Sciences and their groundbreaking research investigating whether the Company's proprietary CBD-like molecules can help change the medical landscape and offer several new treatments for specific ailments. "We are honored to be featured in this Dateline NBC special and thankful to be able to educate people on the therapeutic benefits of cannabinoids and how companies like Kannalife are working to conduct the necessary research on cannabinoid-like molecules to bring new drugs to market," said Kannalife Sciences CEO Dean Petkanas.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Garners International News Coverage on Leading News and Pop Culture Website BuzzFeed

    SAN DIEGO, May 17, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered international news coverage on leading news and pop culture website BuzzFeed. A Guide" talks about the many health and wellness benefits of cannabidiol (CBD) and quotes Medical Marijuana, Inc. CEO Dr. Stuart Titus throughout on how CBD works and the research that is being done to provide evidence for its many uses. The top news and lifestyle website, which boasts an audience of over 18 million unique global monthly views, is targeted at millennial consumers, pop culture enthusiasts and busy professionals looking for an all-inclusive place to get their news.